Splice Variants of the Forkhead Box Protein AFX Exhibit Dominant Negative Activity and Inhibit AFXα-Mediated Tumor Cell Apoptosis
2008
AFX Variants in Cancer and Their Role in Tumor Cell Death
publication
Evidence: moderate
Author Information
Author(s): Lee Eun Jig, Kim Jeong Mo, Lee Mi Kyung, Jameson J. Larry
Primary Institution: Yonsei University College of Medicine
Hypothesis
The study investigates the expression and role of AFX variants in cancer cells and their impact on apoptosis.
Conclusion
The study concludes that AFX variants exhibit dominant negative activity, inhibiting AFXα-mediated tumor cell apoptosis.
Supporting Evidence
- AFX variants were found to suppress the expression of BCL6 and cyclin D2.
- Cell viability assays showed that AFXα suppressed tumor cell growth, while AFXζ and α(198-505) did not.
- The study identified novel splicing variants of AFX in human cancer cells.
Takeaway
Some proteins in cancer cells can stop other proteins from making the cells die, which helps the cancer cells survive longer.
Methodology
The study used cell transduction, PCR amplification, Western blotting, and luciferase reporter assays to analyze AFX variants.
Limitations
The study does not explore the in vivo effects of AFX variants in primary tumors.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website